[Specific features of detection of caseous pneumonia and its course in Samara]

Problemy Tuberkuleza I Boleznei Legkikh
|February 16, 2007
PubMed

Insights

This study on caseous pneumonia in Samara found that unemployed males over 35, not screened for over two years, were most affected. High drug resistance and delayed diagnosis contributed to a significant one-year mortality rate.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Epidemiology

Context:

  • Caseous pneumonia analysis in 163 patients in Samara.
  • Focus on demographic, clinical, and microbiological characteristics.
  • Investigation of risk factors and outcomes.

Purpose:

  • To characterize caseous pneumonia in the Samara region.
  • To identify risk factors, including drug resistance and diagnostic delays.
  • To assess the one-year mortality and disease progression.

Summary:

  • The study identified males aged 35-60, the unemployed, and those with infrequent chest X-rays (CC-fluorography) as high-risk groups.
  • Bilateral lung involvement, extensive tissue destruction, and primary drug resistance (30.8%) were common findings.
  • Classical presentation occurred in 75.5%, but diagnosis took an average of one month, leading to a 34.6% one-year mortality rate.

Impact:

  • Highlights the significant burden of caseous pneumonia in the studied population.
  • Emphasizes the need for improved early diagnosis and treatment strategies.
  • Underscores the role of chronic forms in maintaining tuberculosis infection reservoirs.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...